https://www.selleckchem.com/pr....oducts/lotiglipron.h
ven disease process, thus offering the possibility of identifying an underlying retinopathy long before its clinical manifestation and consequently optimize its management. Acute orbital inflammation can lead to irreversible vision loss in serious cases. Treatment thus far has been limited to systemic steroids or surgical decompression of the orbit. An animal model that mimics the characteristic features of acute orbital inflammation as found in thyroid eye disease can be used to explore novel treatment modalities. We developed a mu